THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 107 filers reported holding THERAVANCE INC in Q2 2015. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $46,571,000 | +37.4% | 4,418,480 | -6.4% | 0.01% | +22.2% |
| Q3 2015 | $33,890,000 | -58.4% | 4,720,060 | +4.8% | 0.01% | -55.0% |
| Q2 2015 | $81,376,000 | +15.8% | 4,503,402 | +0.8% | 0.02% | +17.6% |
| Q1 2015 | $70,254,000 | +14.4% | 4,469,076 | +3.0% | 0.02% | +13.3% |
| Q4 2014 | $61,388,000 | +1.5% | 4,338,384 | +22.6% | 0.02% | -11.8% |
| Q3 2014 | $60,481,000 | -44.1% | 3,538,981 | -2.7% | 0.02% | -43.3% |
| Q2 2014 | $108,278,000 | +51.1% | 3,635,943 | +57.0% | 0.03% | +42.9% |
| Q1 2014 | $71,647,000 | -3.9% | 2,315,682 | +10.7% | 0.02% | -8.7% |
| Q4 2013 | $74,568,000 | -4.2% | 2,091,669 | +9.8% | 0.02% | -11.5% |
| Q3 2013 | $77,843,000 | +25.7% | 1,904,637 | +18.5% | 0.03% | +13.0% |
| Q2 2013 | $61,941,000 | – | 1,607,605 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 19,815,983 | $338,655,000 | 5.90% |
| Litespeed Management, L.L.C. | 2,670,695 | $45,642,000 | 1.76% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,790,913 | $47,697,000 | 1.76% |
| Proxima Capital Management, LLC | 915,000 | $15,637,000 | 1.69% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,196,372 | $140,076,000 | 1.44% |
| PERRY CAPITAL | 1,831,099 | $31,293,000 | 1.14% |
| Roundview Capital LLC | 140,145 | $2,395,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 971,438 | $16,602,000 | 0.70% |
| Realm Partners LLC | 139,982 | $2,392,000 | 0.68% |
| BB BIOTECH AG | 743,244 | $12,702,000 | 0.52% |